The Endobronchial Ultrasound Biopsy market is estimated to be valued at US$ 722.67 Bn in 2023 and is expected to exhibit a CAGR of 9.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market OverviewEndobronchial ultrasound biopsy (EBUS) is a minimally invasive medical procedure used to diagnose and stage lung cancer and mediastinal...
The endobronchial ultrasound biopsy market includes endoscopes and ultrasound devices that are used to obtain samples from enlarged lymph nodes inside the chest for diagnostic purposes. Endobronchial ultrasound biopsy helps physicians to diagnose various lung conditions including cancer by providing real-time images of the lungs and mediastinum. EBUS biopsy procedures allow doctors to access...
Endobronchial ultrasound biopsy (EBUS-TBNA) is a minimally invasive medical procedure used to examine mediastinal and hilar lymph nodes in pulmonary malignancies. It helps in the diagnosis and staging of lung cancer and sarcoidosis. EBUS-TBNA uses an ultrasound bronchoscope, which incorporates an ultrasound probe at its tip. With real-time ultrasound imaging, suspicious lymph nodes can be...
The Endobronchial Ultrasound Biopsy Market is estimated to be valued at Us$ 529.7 Mn or in 2022 and is expected to exhibit a CAGR Of 4.6% over the forecast period 2017-2025, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Endobronchial ultrasound biopsy is a bronchoscopic technique used to obtain samples from lung lesions or lymph nodes around the...